Showing posts with label congress. Show all posts
Showing posts with label congress. Show all posts

Thursday, January 19, 2017

A social scientist’s guide to the Final Rule

On 18 January 2017, sixteen federal agencies announced revisions to the Federal Policy for the Protection of Human Subjects. As I noted earlier, this marks a huge victory for historians, who have spent the last 20 years working to end the inappropriate interference of IRBs with oral history research.


In addition, the final rule includes several provisions of note to scholars in the humanities and social sciences. Here are some of them; I don’t claim it is a complete list.

Saturday, January 7, 2017

Common Rule reform still in suspense

A proposed final rule on human subjects protections made it to the Office of Management and Budget on Wednesday, January 4.


Jeannie Baumann of Bloomberg thinks this means that we’ll see it in the Federal Register before January 20. But she also quotes Lisa Nichols, director of research and regulatory reform for Council on Governmental Relations, predicting that Congress will overturn the reform, since it appears on the House Freedom Caucus hit list.


Wake me up when it’s over.


[Jeannie Baumann, “White House Takes Final Steps to Revamp Medical Research Rule,” Bloomberg BNA, January 6, 2017.]

Wednesday, December 7, 2016

Will Cures Act Replace Common Rule Reform?

As of November 15, POLITICO thinks that Common Rule reform is dead:


HHS’s controversial revision of the Common Rule, the regulations that protect participants in clinical research, still hasn’t been sent to OMB for review. That’s not likely to get finished under Obama’s watch.


(David Pittman, “Obama’s HHS, Congress at Potential Odds over Pending Rule,” POLITICO, November 15, 2016)


On the other hand, Congress just passed the 21st Cures Act, which includes a provision for a Research Policy Board designed, as Science puts it, to “examine excessive regulation of research.”


In his September 29 testimony before the Subcommittee on Research and Technology, James Luther of Duke University suggested that the congressional effort could replace the executive one. He complained “that HHS is still trying to move forward with a final rule [for human subjects research] for which many of the proposals remain unchanged from the ANPRM despite overwhelmingly negative comments” about its provisions on biospecimens. And he suggested that a Research Policy Board might do a better job.


Perhaps such a board would attend to questions of concern to the social sciences and humanities, but I am not hopeful. Luther’s testimony cites the May 2016 analysis by the Council on Governmental Relations (COGR) and the Association of Public and Land-grant Universities (APLU) and the June report by the National Academies of Sciences, Engineering, and Medicine’s Committee on Federal Research Regulations and Reporting Requirements. Both of those documents mostly ignored the social sciences and humanities.


The sun never sets on the Ethical Empire.

Saturday, June 6, 2015

Klitzman Wants "Case Law." As Did Katz, 42 Years Ago

In an opinion piece drawn from his new book, The Ethics Police?, Robert Klitzman calls for IRB transparency and respect for precedent. That is a good idea, and one that should have been implemented decades ago.


[Robert Klitzman, “Who Polices the ‘Ethics Police’?,” CNN, May 26, 2015]


Thursday, April 26, 2012

Beauchamp and Saghai on the Mystery of Generalizable Knowledge

Philosophers Tom L. Beauchamp and Yashar Saghai find that although never defined, "the criterion of generalizable knowledge . . . is the foundation stone of the [National] Commission's conceptual and moral scheme in Belmont and beyond.

[Tom Beauchamp and Yashar Saghai. "The Historical Foundations of the Research-Practice Distinction in Bioethics," Theoretical Medicine and Bioethics 33, no. 1 (2012): 45–56. DOI 10.1007/s11017-011-9207-8. h/t Nathan Emmerich.]

Tuesday, May 5, 2009

DeGette Still Doesn't Get It

Representative Diana DeGette (D-CO) has introduced the Protection for Participants in Research Act (H.R. 1715), which would impose IRB requirements on all human subject research supported by the federal government or affecting interstate commerce.

As amp&rsand notes, this is the sixth time DeGette has introduced this bill. And I don't think that counts earlier submissions of similar bills by Senator John Glenn. None of these previous efforts went far, so there's no particular reason to fear this bill's passage.

Still, it is disappointing that DeGette has introduced this bill six times without understanding its potential consequences. Her press release states that “I think one thing we can all agree on in a bipartisan way is that we need to encourage medical experimentation but we need to do it in a way that both protects the patients and gives them informed consent about what they are getting into," as if the bill would affect only medical experimentation. It points to medical trials in 1999 and 2006 as evidence of insufficient oversight, and argues that "research is the key to innovation and discovery, including curing deadly disease." Nowhere in the press release is a hint that DeGette understands that her bill would outlaw most journalism, not to mention further inhibiting social science and humanities research.

Thirty-five years after the passage of the National Research Act, Congress still doesn't know what it has done.

Bonus question for Rebecca Tushnet's 43(B)log: Is the copyright claim on DeGette's press release--the work of a federal employee in her official capacity--illegal, or merely false?

Update 8 May 2009: A correspondent notes that the copyright statement is no longer on the site. If DeGette removed the statement in response to this blog, good for her. I have a PDF of the press release as it appeared on May 4, if anyone is interested.